drugset / Trial / NCT01729884
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial studies how well vaccine therapy works in treating patients with stage IV hormone receptor positive breast cancer. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells.
Timeline
- Start
- 2012-12
- Primary completion
- 2013-06
- Completion
- —
Outcome
Outcome not reported
Stopped (Enrollment): “Study ended early due to slow enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HER-2/neu peptide vaccine | Vaccine | — | Other |